Science & Space ·
News
About 12 More in 100 Melanoma Patients Stay Cancer-Free With a Custom Vaccine
Adding a vaccine tailored to each patient's tumour improved outcomes after surgery for high-risk melanoma. Independent researchers see a possible approval next year, while price could become a barrier to access.
Read the story · 4 min